For: | Pan X, Wang Y, Zhang M, Pan W, Qi ZT, Cao GW. Effects of endostatin-vascular endothelial growth inhibitor chimeric recombinant adenoviruses on antiangiogenesis. World J Gastroenterol 2004; 10(10): 1409-1414 [PMID: 15133844 DOI: 10.3748/wjg.v10.i10.1409] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v10/i10/1409.htm |
Number | Citing Articles |
1 |
Zhisong Zhang, Lu-Yuan Li. TNFSF15 Modulates Neovascularization and Inflammation. Cancer Microenvironment 2012; 5(3): 237 doi: 10.1007/s12307-012-0117-8
|
2 |
ZHAO-NA LI, ZHONG-FANG YUAN, GUO-YING MU, MING HU, LI-JUN CAO, YA-LI ZHANG, MING-XU GE. Augmented anti-angiogenesis activity of polysulfated heparin-endostatin and polyethylene glycol-endostatin in alkali burn-induced corneal ulcers in rabbits. Experimental and Therapeutic Medicine 2015; 10(3): 889 doi: 10.3892/etm.2015.2602
|
3 |
Zhen-Tian Cui, Jian-Ping Liu, Jian-Min Yao. Antagonistic effects of endostatin-vascular endothelial growth inhibitor chimeric recombinant adenovirus on homocysteine-induced vascular endothelial cells injury in vitro and in vivo. Medicine 2016; 95(44): e5197 doi: 10.1097/MD.0000000000005197
|
4 |
Ye-Fen Xu, Li-Ping Zhu, Bi Hu, Zhi-Gang Rong, Hao-Wen Zhu, Jia-Ming Xu, Zhi-Wei Wu, Jian-Jun Wang, Gen-Xing Xu. A quantitative method for measuring the antitumor potency of recombinant human endostatin in vivo. European Journal of Pharmacology 2007; 564(1-3): 1 doi: 10.1016/j.ejphar.2007.01.086
|
5 |
Jing Sang, Kai Yang, Yueping Sun, Yan Han, Hui Cang, Yuying Chen, Guiying Shi, Kangmin Wang, Jie Zhou, Xiangrui Wang, Jing Yi.
SUMO2 and SUMO3 transcription is differentially regulated by oxidative stress in an Sp1-dependent manner. Biochemical Journal 2011; 435(2): 489 doi: 10.1042/BJ20101474
|
6 |
Dimitris Zacharoulis, Constantine Hatzitheofilou, Evangelos Athanasiou, Stergios Zacharoulis. Antiangiogenic strategies in hepatocellular carcinoma: current status. Expert Review of Anticancer Therapy 2005; 5(4): 645 doi: 10.1586/14737140.5.4.645
|
7 |
Linda J. Metheny-Barlow, Lu-Yuan Li. Vascular Endothelial Growth Inhibitor (VEGI), an Endogenous Negative Regulator of Angiogenesis. Seminars in Ophthalmology 2006; 21(1): 49 doi: 10.1080/08820530500511446
|
8 |
Xinke Zhang, Yan Li, Yanna Cheng, Haining Tan, Zhiwei Li, Yi Qu, Guoying Mu, Fengshan Wang. Tat PTD–endostatin: A novel anti-angiogenesis protein with ocular barrier permeability via eye-drops. Biochimica et Biophysica Acta (BBA) - General Subjects 2015; 1850(6): 1140 doi: 10.1016/j.bbagen.2015.01.019
|
9 |
J Zhou, Z Yang, T Tsuji, J Gong, J Xie, C Chen, W Li, S Amar, Z Luo. LITAF and TNFSF15, two downstream targets of AMPK, exert inhibitory effects on tumor growth. Oncogene 2011; 30(16): 1892 doi: 10.1038/onc.2010.575
|
10 |
Ying Yang, Bo Gong, Zheng‐Zheng Wu, Ping Shuai, Dong‐Feng Li, Ling‐Lin Liu, Man Yu. Inhibition of microRNA‐129‐5p expression ameliorates ultraviolet ray‐induced corneal epithelial cell injury via upregulation of EGFR. Journal of Cellular Physiology 2019; 234(7): 11692 doi: 10.1002/jcp.27837
|
11 |
Natália Meneses Araújo, Ileana Gabriela Sanchez Rubio, Nicholas Pietro Agulha Toneto, Mirian Galliote Morale, Rodrigo Esaki Tamura. The use of adenoviral vectors in gene therapy and vaccine approaches. Genetics and Molecular Biology 2022; 45(3 suppl 1) doi: 10.1590/1678-4685-gmb-2022-0079
|
12 |
Shan Yan, Xuxu Sun, Binggang Xiang, Hui Cang, Xunlei Kang, Yuying Chen, Hui Li, Guiying Shi, Edward T H Yeh, Beilei Wang, Xiangrui Wang, Jing Yi. Redox regulation of the stability of the SUMO protease SENP3 via interactions with CHIP and Hsp90. The EMBO Journal 2010; 29(22): 3773 doi: 10.1038/emboj.2010.245
|
13 |
Haining Tan, Shenglin Yang, Chunhui Liu, Jichao Cao, Guoying Mu, Fengshan Wang. Enhanced anti-angiogenesis and anti-tumor activity of endostatin by chemical modification with polyethylene glycol and low molecular weight heparin. Biomedicine & Pharmacotherapy 2012; 66(8): 648 doi: 10.1016/j.biopha.2011.04.007
|
14 |
Salvatore Grisanti, Olcay Tatar. The role of vascular endothelial growth factor and other endogenous interplayers in age-related macular degeneration. Progress in Retinal and Eye Research 2008; 27(4): 372 doi: 10.1016/j.preteyeres.2008.05.002
|
15 |
Gautam Sethi, Bokyung Sung, Bharat B. Aggarwal. Therapeutic Targets of the TNF Superfamily. Advances in Experimental Medicine and Biology 2009; 647: 207 doi: 10.1007/978-0-387-89520-8_15
|
16 |
Feng Jiang, Qingzhong Chen, Liming Huang, Ying Wang, Zhuhong Zhang, Xiangda Meng, Yuanyuan Liu, Chunjie Mao, Fang Zheng, Jingkai Zhang, Hua Yan. TNFSF15 Inhibits Blood Retinal Barrier Breakdown Induced by Diabetes. International Journal of Molecular Sciences 2016; 17(5): 615 doi: 10.3390/ijms17050615
|
17 |
O Tatar, K Shinoda, E Kaiserling, C Claes, C Eckardt, T Eckert, G Pertile, V Boeyden, G B Scharioth, E Yoeruek, P Szurman, K U Bartz-Schmidt, Tuebingen Bevacizumab Study Group, S Grisanti. Implications of bevacizumab on vascular endothelial growth factor and endostatin in human choroidal neovascularisation. British Journal of Ophthalmology 2009; 93(2): 159 doi: 10.1136/bjo.2008.138594
|